Neurology
2 drugs are in development for Idiopathic Hypersomnia.
- Companies
- 2
- Clinical trials
- 13
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Idiopathic Hypersomnia pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| ORX750 | Centessa Pharmaceuticals plc (CNTA) |
Phase 4(1)
| Drug | Company |
|---|---|
| Xywav | Jazz Pharmaceuticals plc (JAZZ) |
About this indication
Idiopathic Hypersomnia context
Neurology·MeSH: Idiopathic Hypersomnia (D020177)
Also known as: CNS Hypersomnolence, Idiopathic, CNS Hypersomnolences, Idiopathic, Hypersomnias, Idiopathic, Hypersomnolence, CNS, Idiopathic, Hypersomnolences, Idiopathic, Idiopathic Central Nervous System Hypersomnolence, Idiopathic Hypersomnolence
Frequently asked questions
How many drugs are in development for Idiopathic Hypersomnia?
BioSniper tracks 2 drugs in development for Idiopathic Hypersomnia across 2 companies.
How many clinical trials target Idiopathic Hypersomnia?
There are 13 clinical trials targeting Idiopathic Hypersomnia tracked by BioSniper.